The monoclonal antibody A60 specifically recognizes the DNA-binding, neuron-specific protein NeuN, which is present in most neuronal cell types of vertebrates. In this study we demonstrate the potential use of NeuN as a diagnostic neuronal marker using a wide range of formalin-fted, pataffin-embedded human surgical and autopsy specimens from the central and peripheral n m u s system. After microwave antigen retrieval, almost all neuronal populations revealed strong immunoreactivity for NeuN in nuclei, perikarya, and some proximal neuronal p r o " , whereas more distal axon cylinders and dendritic ramifications were not stained. The stain greatly enhanced the gray matter architecture. NeuN immunoreactivity was not detected in Purkinje cells, most neurons of the internal nuclear layer of the
Introduction
A specific and sensitive marker for neuronal somata in routinely prepared formalin-fixed, paraffin-embedded human tissue seaions is not readily available. The traditional Nissl stains highlight large ganglion cells with abundant ribosomes, but many small cortical interneurons or granule cells of the cerebellum and dentate gyrus remain difficult to distinguish from glial cells. The Golgi stain, another traditional method to visualize neurons and their processes, requires lengthy impregnation of fresh tissues and cannot be used retrospectively in routinely processed tissues. For unknown reasons, it labels only a small percentage of neurons. In the era of immunohistochemistry, antibodies to neuron-specific enolase (NSE), chromogranin, neurofilament protein, and synaptophysin are widely utilized for visualization of neuronal structures. However, NSE is not specific for the neuronal lineage, as was originally believed Supported by grants from the Deutsche Forschungsgemeidmft (WO 57112-1) and the University of Bonn Medical Center. (Schmechel, 1985; Vinores et al., 1984) . Chromogranins are afamily of highly acidic glycoproteins that are associated with neurosecretory granules of various cell types. Although chromogranins are present in neurons of the central and peripheral nervous system, their immunohistochemical detection in formalin-fixed, paraffinembedded human brain tissue has been unsatisfactory with a panel of different antibodies (Munoz et al., 1990; Schmid et al., 1989; Nolan et al., 1985; Somogyi et al.. 1984) .
Synaptophysin is a membrane glycoprotein which is localized in presynaptic vesicles, and therefore synaptophysin immunoreactivity is diffusely distributed throughout the neuropil, whereas there is no consistent labeling of neuronal somata (Miller et al., 1990; Gould et al., 1986) . Neurofilament proteins are major components of the neuronal cytoskeleton. However, depending on their molecular weight and degree of phosphorylation, the immunoreactivity for neurofilament proteins is highly variable. In addition, the somata of small intemeurons contain little, if any, neurofilament proteins (Schlaepfer? 1987; Trojanowski, 1987; Shaw et al., 1987) .
In the present study we examined the new monoclonal antibody (MAb) A60 with respect to its potential use as a neuronal marker in diagnostic histopathology. The MAb A60 was generated against brain cell nuclei and recognizes the neuron-specific pro-1168 WOLF, BUSLEI, SCHMIDT-KAS"ER, SCHMIDT-KASTNER, PETSCH, WIESTLER, BmMCKE tein NeuN (neuronal nuclei). It labels nuclei and perikarya of most neuronal cell types throughout the nervous system of adult mice and crossreacts hmunohistochemically with neural tissue from rats, chicks, humans, and salamanders (Mullen et al., 1992) . NeuN is a soluble nuclear protein that binds to DNA in vitro. On immunoblots, NeuN appears as three bands (46) (47) (48) . Its function is still unknown.
Developmentally, NeuN expression occurs in association with terminal neuronal differentiation (Mullen et al., 1992) . Recently, NeuN has been used to identify neurons in transplantation studies of embryonal carcinoma cell lines (Morassutti et al., 1994) and of neuronal progenitor cells (Gage et al., 1995) . The MAb A60 is unrelated to the neuronal cytoskeleton protein that has been also designated A60 (Hayes et al., 1995) .
We have studied NeuN immunoreactivity in a wide spectrum of neurons of the human central and peripheral nervous system and in ganglion cell tumors. Our goal was to determine if the immunoreactivity with MAb A60 is a specific and useful marker for neuronal somata in routinely processed formalin-fixed, paraffinembedded human tissues from surgical and autopsy specimens.
Materials and Methods
To examine a wide range of normal and abnormal human ganglion cells at various anatomic sites, archival tissue samples from surgical specimens and autopsies were retrieved from the files of the Departments of Neuropathology and Pathology, University of Bonn Medical Center. The autopsy specimens originated from histologically normal neocortex, hippocampus, basal ganglia, thalamus, hypothalamus, pineal, midbrain, pons, cerebellum, medulla oblongata, spinal cord, eye, and sympathetic chain ganglia. Representative surgical specimens of histologically normal neocortex, hippocampus, pineal, cerebellum, sensory ganglia, small intestine, pituitary, and adrenal were selected. In addition, we examined nine gangliogliomas, 14 dysembryoplastic neuroepithelial tumors (DNTs), seven medulloblastomas, one ganglioneuroma. and one dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease). Furthermore, we examined a representative set of surgical specimens from non-neuronal tumors that are frequently encountered in surgical neuropathology [six cases of glioblastoma multiforme. five diffusely infiltrating astrocytomas (WHO Grade 11). five oligodendrogliomas (WHO Grade II), and 17 cases of metastatic carcinoma to the brain]. All surgical specimens had been fixed in neutral buffered formalin at room temperature (RT) for 8 hr to 3 days. The autopsy specimens had been fixed in neutral buffered formalin from 8 hr to 4 weeks. The time interval between death and autopsy (postmortem degradation) ranged from 1 to 4 days. All tissue samples had been routinely processed into paraffin.
Immunohistochemistry. The following protocol for immunohistochemistry provided the best and most consistent staining result. The sections were cut at 4 pm, mounted on slides coated with 3-aminopropyltriethoxysilane (Fisher Scientific; Pittsburgh, PA), air-dried in an incubator at 40"C, and heated on a 60°C hotplate for a few seconds until the paraffin melted. After deparaffinization and rinses in 100% and 95% ethanol, the slides were incubated in 2% hydrogen peroxide diluted in methanol for 15 min, rehydrated in 95% ethanol, and rinsed in PBS with 1% bovine serum albumin (BSA). PBS with 1% BSA was also used for the subsequent washes and dilutions unless otherwise specified.
The slides were then placed in a 0.1 molar citrate buffer at pH 6.0 and heated in a microwave Oven for 30 min at maximal power. The buffer solution was boiling during the microwave treatment. The slides were allowed to cool for 15 min in this buffer solution at RT and subsequently washed in PBS. At this point, preincubation with normal horse serum diluted in PBS was performed. This was followed by incubation with the primary antiNeuN MAb A60 (kindly provided by Dr. R. J. Mullen) at 22°C for 20 hr using a 1:>00 dilution (final IgG concentration 0.05 pglml). The primary antibody was obtained as a culture supernatant. The sections were then incubated with a biotinylated secondary horse anti-mouse immunoglobulin antibody (Vector Laboratories; Burlingame, CA) diluted 1:200 in PBS at 42°C for 1 hr. This was followed by incubation with avidin-biotinylated horseradish peroxidase complex (Vectastain Elite ABC; Vector Laboratories) for 1 hr at 42°C according to the instructions of the manufacturer. All steps were followed by appropriate washes in PBS. Finally, the sections were developed in a substrate solution of 0.05% diaminobenzidine tetrahydrochloride and 0.01% hydrogen peroxide in 0.05 M Tris-HC1. pH 7.6, washed, lightly counterstained with hematoxylin, dehydrated in ethanol, and mounted. Negative control sections were prepared by substitution of the primary antibodies with equivalent dilutions of normal mouse IgG or PBS with 1% BSA.
Results
Almost all neuronal cell populations were immunoreactive for NeuN (Figures 1-8) . The staining was present in both nuclei and cytoplasm and extended into the proximal neuronal processes, whereas more distal axon cylinders and dendritic ramifications were unlabeled. There was no immunoreactivity in the white matter except for scattered ectopic ganglion cells. Of all neuronal populations that were studied in the brain and spinal cord, only Purkinje cells were consistently immunonegative for NeuN, whereas the cerebellar granule cells showed strong immunoreactivity (Figure 2 ). In the retina, the photoreceptor cells and most cells in the inner nuclear layer showed no immunoreactivity for NeuN, but the ganglion cells and a few cells of the inner nuclear layer were strongly labeled ( Figure  3 ). In the peripheral nervous system, there was staining of ganglion cells in sensory ganglia (Figure 4 ) and in the submucosal plexus (Meissner) and myenteric plexus (Auerbach) of the intestines (Figure 5) . Similar to the central nervous system, peripheral neuronal processes were immunonegative for NeuN. No immunoreactivity was detected in the pineal, sympathetic chain ganglia, the adrenal medulla, the pituitary, and in intestinal neuroendocrine cells. In all cases the staining was confined to neurons. We did not observe staining of non-neuronal structures such as glia, satellite cells, Schwann cells, or other structures. Despite microwave treatment, there was no nonspecific background staining.
In all ganglion cell tumors examined (nine gangliogliomas, 14 DNS, one dysplastic cerebellar gangliocytoma, and one sympathetic chain ganglioneuroma), there was striking NeuN immunoreactivity of lesional ganglion cells (Figures 6 and 7) . In addition, in DNlS some of the oligodendroglia-like cells with small round nuclei and perinuclear halos were also NeuN-immunoreactive (Figure 7 ). Neoplastic and reactive astrocytes were always unlabeled. The distinction of preexisting cortical neurons in the infiltration zone of a tumor and lesional ganglion cells was greatly facilitated by NeuN staining. Of seven medulloblastomas, weak NeuN immunoreactivity was seen only focally in one case with prominent neuronal differentiation, as indicated by formation of pseudorosettes and immunoreactivity for synaptophysin. In areas at which the medulloblastoma infiltrated the cerebellar cortex, NeuN expression was very helpful in distinguishing tumor cells from preexisting granule cells (Figure 8) . None of the 33 non-neuronal neoplasms showed nuclear immunoreactivity. A very faint cytoplasmic staining without accompanying nuclear immunoreactivity was seen in two cerebral carcinoma metastases (one small-cell carcinoma and one undifferentiated large-cell carcinoma).
In surgical specimens the neuronal labeling was consistently intense and varied little between different cases. Autopsy specimens showed a more variable immunoreactivity for NeuN. Optimal staining was seen after fixation periods of approximately 8 hr, such as used in surgical specimens, but fixation periods for up to 2 weeks still resulted in satisfactory NeuN immunoreactivity. A weaker reaction detecting only a fraction of the ganglion cells was noted if the tissues were fixed in formalin for more than 2 weeks. There was no correlation between NeuN staining and the time period of postmortem tissue degradation, as determined by the interval between death and autopsy.
Discussion
Our results demonstrate that NeuN is a sensitive and specific neuronal marker in human tissue sections. Almost all neuronal cell types of the central and peripheral nervous system, including small interneurons such as cerebellar granule cells, are immunoreactive for NeuN. The fact that the antigen can be detected in routinely formalin-fixed, paraffin-embedded tissue sections makes MAb A60 appealing for a potential use in diagnostic histopathology. MAb Original magnification x 500. Bar = 10 pm. A60 stains only neuronal somata and proximal processes, and thus supplements the immunoreactivity patterns of neurofilament proteins and synaptophysin. One diagnostic application of MAb A60 may be the definitive identification of neuronal elements in ganglion cell tumors or hamartomas, in which a distinction between atypical glial cells and neurons may be difficult (Miller et al., 1990) . This potential utilization is emphasized by the fact that lesional neurons were strongly immunoreactive in all ganglion cell tumors examined. Some oligodendrocyte-like cells in DNT were also positive for NeuN. This observation is consistent with the presence of other neuronal markers in some of these cells in association with ultrastructural data that demonstrate a neuronal differentiation in at least some oligodendrocyte-like cells in DNT (Hirose et al., 1994) . Recently, it has been demonstrated in experimental animals that NeuN staining may be helpful for quantitative or semiquantitative evaluation of neuronal cell loss in ischemic damage (Schmidt-Kastner et al., 1995) . Similarly, it may be used for the study of neuronal loss in epilepsy, neurodegenerative diseases, or other conditions. The high specificity for neurons and the dense labeling of even small interneurons renders NeuN preparations suitable for semiautomated evaluation of neuronal densities by computer-assisted image analysis. Finally, the striking enhancement of the cortical lamination in NeuN preparations may facilitate the evaluation of subtle architectural disturbances such as microdysgenesis, ectopic neurons, glioneuronal hamartias, and other neuronal migration disorders.
WOLF, BUSLEI. SCHMIDT-KASTNER, SCHMIDT-KASTNER, PIETSCH, WIESTLER, BLUMCKE
There are only a few exceptions to neuronal immunoreactivity for NeuN. As previously shown in mice, human Purkinje cells, photoreceptor cells, and most neurons of the inner nuclear layer of the retina are consistently negative. Sympathetic chain ganglia obtained at autopsy were also nonimmunoreactive for NeuN. The lack of NeuN immunoreactivity in these neurons is difficult to explain without a full understanding of the biological function of the NeuN protein. The observation that some of the NeuN-negative ganglion cell populations electively degenerate in the Purkinje cell degeneration (pcd) mutant mouse may be a key to the answer to this question (Mullen et al., 1992 ).
In conclusion, although the NeuN protein has not been fully characterized, NeuN immunoreactivity is a sensitive and specific neuronal marker in formalin-fixed, paraffin-embedded tissue sections. It may greatly facilitate the evaluation of ganglion cell tumors and hamartomas, neuronal migration disorders, and the assessment of neuronal loss in neurodegenerative diseases, hypoxic-ischemic damage, and in epilepsy and related disorders.
